Table A.15.2
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
Size | 2014 | 2015 |
---|---|---|
$ thousands | ||
Small (less than 50 employees) | ||
Total In-house R&D expenditures | 81,313Table A.15.2 Note D | 66,983Table A.15.2 Note D |
Current in-house R&D expenditures | 53,738Note E: Use with caution | 46,327Table A.15.2 Note D |
Capital in-house R&D expenditures | 27,575Note E: Use with caution | 20,656Note E: Use with caution |
Medium (50 to 149 employees) | ||
Total In-house R&D expenditures | 30,806Note E: Use with caution | 35,040Note E: Use with caution |
Current in-house R&D expenditures | Note x: suppressed to meet the confidentiality requirements of the Statistics Act | 31,067Note E: Use with caution |
Capital in-house R&D expenditures | Note x: suppressed to meet the confidentiality requirements of the Statistics Act | 3,973Note E: Use with caution |
Large (more than 149 employees) | ||
Total In-house R&D expenditures | 9,491Note E: Use with caution | 10,109Note E: Use with caution |
Current in-house R&D expenditures | Note x: suppressed to meet the confidentiality requirements of the Statistics Act | 9,210Note E: Use with caution |
Capital in-house R&D expenditures | Note x: suppressed to meet the confidentiality requirements of the Statistics Act | 899Note E: Use with caution |
x suppressed to meet the confidentiality requirements of the Statistics Act E use with caution Note: Coefficient of variation (CV) threshold
Due to rounding, components may not add to totals. Coefficient of variation (CV) and standard error (SE) are used as quality indicators. Source: Statistics Canada, Bioproducts production and development survey 2015. |
- Date modified: